The 2019 ISPE Annual Meeting & Expo will focus on excellence, modernization, and harmonization in pharmaceutical science and manufacturing across the globe, offering pharma professionals the opportunity to engage in industry-critical conversations. A comprehensive education program provides attendees with technical sessions on the latest developments in supply chain, facilities & equipment, information systems, product development & production systems, quality systems & regulatory oversight and cutting-edge industry innovations. This signature event draws pharmaceutical and biopharmaceutical professionals at all levels of the industry from young professionals to the most senior executives in drug manufacturing, supply chain, devices and equipment and services, and global regulatory agencies.
Four-Day Conference Featuring:
6 extensive education tracks on industry-critical initiatives—focusing on excellence, modernization, and harmonization in pharmaceutical science and manufacturing
85+ hours of targeted technical sessions, from both industry and regulatory leaders
24+ hours of networking opportunities, including:
50+ Plenary and Technical Sessions
Facility of the Year (FOYA) Awards Program
Membership Awards Program
5K Charity Run/Walk
Young Professionals Events
Women in Pharma Events
200+ exhibitors featuring cutting-edge technologies and services
Why You Should Attend the 2019 ISPE Annual Meeting & Expo
Raise your level of technical knowledge through peer-reviewed non-commercial education content from recognized experts in the field
Expand your professional network throughout the conference in educational sessions, the exhibit hall, and numerous special events
Enhance your individual and company’s recognition among industry colleagues through face-to-face interaction
Facilities and Equipment
Innovation in Pharmaceutical Engineering
Process Development and Manufacturing
Quality Systems & Regulatory
Supply Chain Management
Who Should Attend?
Professionals at all levels of the industry from young professionals to the most senior executives, Communities of Practice, special interest groups, pharmaceutical industry equipment and services suppliers, regulatory professionals.